The future burden of CKD in the United States: A simulation model for the CDC CKD initiative

American Journal of Kidney Diseases

Volumn 65, Issue 3, 2015, Pages 403-411

  Hoerger, Thomas J ^a   Simpson, Sean A ^a   Yarnoff, Benjamin O ^a   Pavkov, Meda E ^b   Ríos Burrows, Nilka ^b   Saydah, Sharon H ^b   Williams, Desmond E ^b   Zhuo, Xiaohui ^b  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Centers for Disease Control and Prevention CKD Initiative; Chronic kidney disease (CKD); CKD Health Policy Model; disease burden; disease trajectory; lifetime incidence; prevalence; public health; simulation model; United States

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEALTH CARE NEED; HEALTH CARE POLICY; HUMAN; HYPERTENSION; INCIDENCE; MORTALITY; PREVALENCE; PROTEINURIA; PUBLIC HEALTH; RISK FACTOR; SIMULATION; UNITED STATES; COHORT ANALYSIS; COST OF ILLNESS; ECONOMICS; FEMALE; FORECASTING; MALE; MIDDLE AGED; NUTRITION; PUBLIC HEALTH SERVICE; RENAL INSUFFICIENCY, CHRONIC; THEORETICAL MODEL; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COHORT STUDIES; COST OF ILLNESS; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NUTRITION SURVEYS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

EID: 84924044822     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.09.023     Document Type: Article

References (34)

1. A.J. Collins, R.N. Foley, and C. Herzog US Renal Data System 2012 annual data report Am J Kidney Dis 61 1 suppl 1 2013 e1 e480
2. J. Coresh, E. Selvin, and L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 7 2007 2038 2047
3. U.S. Burden of Disease Collaborators The state of US health, 1990-2010: burden of diseases, injuries, and risk factors JAMA 310 6 2013 591 608
4. A.A. Honeycutt, J.E. Segel, X. Zhuo, T.J. Hoerger, K. Imai, and D. Williams Medical costs of CKD in the Medicare population J Am Soc Nephrol 24 9 2013 1478 1483
5. D.S. Tuot, L.C. Plantinga, C.Y. Hsu Centers for Disease Control Chronic Kidney Disease Surveillance Team Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction Clin J Am Soc Nephrol 6 8 2011 1838 1844
6. T.J. Hoerger, J.S. Wittenborn, J.E. Segel Centers for Disease Control and Prevention CKD Initiative A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences Am J Kidney Dis 55 3 2010 452 462
7. T.J. Hoerger, J.S. Wittenborn, J.E. Segel Centers for Disease Control and Prevention CKD Initiative A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening Am J Kidney Dis 55 3 2010 463 473
8. T.J. Hoerger, J.S. Wittenborn, and X. Zhuo Cost-effectiveness of screening for microalbuminuria among African Americans J Am Soc Nephrol 23 12 2012 2035 2041
9. National Kidney Foundation Kidney Disease Outcomes Quality Initiative: part 4. Definition and classification of stages of chronic kidney disease Am J Kidney Dis 39 2 suppl 1 2002 S46 S75
10. L.E. Boulware, B.G. Jaar, M.E. Tarver-Carr, F.L. Brancati, and N.R. Powe Screening for proteinuria in US adults: a cost-effectiveness analysis JAMA 290 23 2003 3101 3114
11. A.I. Adler, R.J. Stevens, and S.E. Manley Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 1 2003 225 232
12. C.C. Cowie, K.F. Rust, and D.D. Bryd-Hold Prevalence of diabetes and impaired fasting glucose in adults in the U.S. Population: National Health and Nutrition Examination Survey 1999-2002 Diabetes Care 29 6 2006 1263 1268
13. L.S. Geiss, L. Pan, B. Cadwell, E.W. Gregg, S.M. Benjamin, and M.M. Engelgau Changes in incidence of diabetes in US adults, 1997-2003 Am J Prev Med 30 5 2006 371 377
14. E. Paoletti, D. Bellino, P. Cassottana, D. Rolla, and G. Cannella Left ventricular hypertrophy in nondiabetic predialysis CKD Am J Kidney Dis 46 2 2005 320 327
15. S. Cottone, E. Nardi, G. Mule, and A. Vadala Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease Clin Nephrol 67 4 2007 209 216
16. K.M. Anderson, P.M. Odell, P.W.F. Wilson, and W.B. Kannnel Cardiovascular disease risk profiles Am Heart J 121 1, pt 2 1991 293 298
17. D.E. Weiner, S. Tabatabai, and H. Tighiouart Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease Am J Kidney Dis 48 3 2006 392 401
18. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
19. E. Arias United States life tables, 2003 Natl Vital Stat Rep 54 14 2006 http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54-14.pdf Accessed July 30, 2007
20. National Center for Health Statistics (NCHS). Worktable 210R: death rates for 113 selected causes, alcohol-induced causes, drug-induced causes, and injury by firearms by 5-year age groups, race, and sex: United States 2003. http://www.cdc.gov/nchs/data/statab/Mortfinal2003-worktable210r.pdf March 2006. Accessed July 30, 2007.
21. R.L. Sacco, T. Shi, M.C. Zamanillo, and D.E. Kargman Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study Neurology 44 4 1994 626 634
22. M.G. Hunink, L. Goldman, and A.N. Tosteson The recent decline in mortality from coronary heart disease, 1980-1990 JAMA 277 7 1997 535 542
23. M.C. Weinstein, B. O'Brien, and J. Hornberger Principles of good practice for decision analytic modeling in health-care evaluation. Report of the ISPOR Task Force on Good Research Practices - Modeling Studies Value Health 6 1 2003 9 17
24. K. Hoang, J.C. Tan, and G. Derby Determinants of glomerular hypofiltration in aging humans Kidney Int 64 4 2003 1417 1424
25. A.S. Levey, L.A. Stevens, C.H. Schmid CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
26. S.I. Hallan, K. Matsushita, Y. Sang Chronic Kidney Disease Prognosis Consortium Age and association of kidney measures with mortality and end-stage renal disease JAMA 308 22 2012 2349 2360
27. Centers for Disease Control and Prevention. Crude and age-adjusted incidence of diagnosed diabetes per 1,000 population aged 18-79 years, United States, 1980-2011. 2012. http://www.cdc.gov/diabetes/statistics/incidence/fig2.htm. Accessed March 23, 2013.
28. American Heart Association Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
29. N. Howlader, A.M. Noone, and M. Krapcho SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) 2012 National Cancer Institute Bethesda, MD http://seer.cancer.gov/archive/csr/1975-2009-pops09/ Accessed September 7, 2012
30. K.M.V. Narayan, J.P. Boyle, T.J. Thompson, S.W. Sorensen, and D.F. Williamson Lifetime risk for diabetes mellitus in the United States JAMA 290 14 2003 1884 1890
31. R.S. Vasan, A. Beiser, and S. Seshadri Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study JAMA 287 8 2002 1003 1010
32. M.E. Grams, E.K. Chow, D.L. Segev, and J. Coresh Lifetime incidence of CKD stages 3-5 in the United States Am J Kidney Dis 62 2 2013 245 252
33. United States Census Bureau. 2012 national population projections: summary tables; Table 12, Projections of the Population by Age and Sex for the United States: 2015 to 2060; Middle Series. Updated May 2013. http://www.census.gov/population/projections/data/national/2012/summarytables.html. Accessed January 6, 2014.
34. M. Rutkowski, W. Mann, and S. Derose Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente Am J Kidney Dis 53 3 suppl 3 2009 S86 S99